|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Cash on hand | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||
| Other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Cash and Investments held in trust | ||||||||||||||||||
| Non-current assets: | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||
| Accounts Payable and accrued offering costs and expenses | ||||||||||||||||||
| Liabilities | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total accrued expenses | ||||||||||||||||||
| Accrued interest expense - others | ||||||||||||||||||
| Promissory notes | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total promissory notes | ||||||||||||||||||
| Promissory Note - Others | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Deferred underwriter compensation | ||||||||||||||||||
| Non-current liabilities: | ||||||||||||||||||
| Related party loan | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Class A ordinary shares subject to possible redemption 43,739 and 751,837 shares at redemption value of $12.54 and $12.00 per share as of June 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||
| Total class A ordinary shares subject to possible redemption 43,739 and 751,837 shares at redemption value of $12.54 and $12.00 per share as of June 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||
| Preferred stock, $0.0001 par value, 45,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 5,423,606 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||
| Common stock, $0.0001 par value, 740,000,000 shares authorized as of June 30, 2026 and December 31, 2025 ; 230,209,142 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||
| Class A Ordinary Shares | ||||||||||||||||||
| Class B Ordinary Shares | ||||||||||||||||||
| Total common stock, $0.0001 par value, 740,000,000 shares authorized as of June 30, 2026 and December 31, 2025 ; 230,209,142 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||
Loading...
